Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Allergy and Asthma Consultants, Wichita, Kansas

Status and phase: Completed; Phase 1

Conditions: Duchenne's Muscular Dystrophy

Treatments: Biological: Umbilical Cord Mesenchymal Stem Cells

Study type: Interventional

Funder types: Other

Identifiers

NCT02235844

IND 16026 DMD Single Patient

Details and patient eligibility

About

This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inflammatory properties of UC MSCs position them as a possible treatment option for DMD. Both of these properties could lead to potential benefits for a DMD patient.

Enrollment: 1 patient

Sex: Male

Ages: 28 to 31 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Duchenne's Muscular Dystrophy

Exclusion criteria

• None

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1 participants in 1 patient group

Mesenchymal Stem Cells

Experimental group

Description:

Umbilical Cord Mesenchymal Stem Cells

Treatment:

Biological: Umbilical Cord Mesenchymal Stem Cells